90K (Mac-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells

International Journal of Cancer

Volumn 79, Issue 1, 1998, Pages 23-26

  Fusco, Ornella ^a   Querzoli, Patrizia ^b   Nenci, Italo ^b   Natoli, Clara ^a   Brakebush, Cord ^c   Ullrich, Axel ^c   Iacobelli, Stefano ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; KI 67 ANTIGEN; MESSENGER RNA; METHOTREXATE; ONCOPROTEIN; PROTEIN P53; TUMOR ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CORRELATION FUNCTION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; BREAST NEOPLASMS; CARRIER PROTEINS; GENE EXPRESSION; GLYCOPROTEINS; HUMANS; KI-67 ANTIGEN; MASTECTOMY; MIDDLE AGED; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; RNA, NEOPLASM; SURVIVAL ANALYSIS;

EID: 0032548873     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980220)79:1<23::AID-IJC5>3.0.CO;2-Y     Document Type: Article

References (24)

1. ARTINI, M., NATOLI, C., TINARI, N., COSTANZO, A., MARINELLI, R., BALSANO, C., PORCARI, P., ANGELUCCI, D., D'EGIDIO, M., LEVRERO, M. and IACOBELLI, S., Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to α-interteron therapy in chronic-HCV-hepatitis patients. J. Hepatol., 25, 212-217 (1996).
2. BADDOURA, F.K., COHEN, C., UNGER, E.R., DEROSE, P.B. and CHENOGIS, M., Image analysis for quantification of estrogen receptor in formalin-fixed paraffin-embedded sections of breast carcinoma. Mod. Pathol., 4, 91-5 (1991).
3. + homosexual men. AIDS Res., 9, 811-816 (1993).
4. COX, D.R., Regression models and life tables. J. roy. statist. Soc., 34, 187-220 (1972).
5. D'OSTILIO, N., SABATINO, G., NATOLI, C., ULLRICH, A. and IACOBELLI, S., 90.K (Mac-2 BP) in human milk. Clin. exp. Immunol., 104, 543-546 (1996).
6. FOEKENS, J.A., KLIJN, A.M., NATOLI, C., VAN PUTTEN, L.J., DI STEFANO, P., LOOK, M.P., PORTENGEN, H. and IACOBELLI, S., Expression of tumor-associated 90K antigen in human breast cancer: no correlation with prognosis and response to first-line therapy with tamoxifen. Int. J. Cancer, 64, 130-134 (1995).
7. IACOBELLI, S., ARNO, E., D'ORAZIO, A. and COLETTI, G., Detection of antigen recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer. Cancer Res., 46, 3005-3010 (1986).
8. IACOBELLI, S., ARNO, E., SISMONDI, P., NATOLI, C., GENTILONI, N., SCAMBIA, G., GIAI, M., CORTESE, P., BENEDETTI PANICU P. and MANCUSO, S., Measurement of breast-cancer-associated antigen detected by monoclonal antibody SP-2 in sera of cancer patients. Breast Cancer Res. Treat., 11, 19-30 (1988).
9. IACOBELLI, S., BUCCI, I., D'EGIDIO, M., GIULIANI, C., NATOLI, C., TINARI, N., RUBINSTEIN, M. and SCHLESSINGER, J., Purification and characterization of a 90 kDa protein released from human tumors and tumor cell lines. FEBS Lett., 319, 59-65 (1993).
10. IACOBELLI, S., SISMONDI, P., GIAI, M., D'EGIDIO, M., TINARI, N., AMATETTI, C., DI STEFANO, P. and NATOLI, C., Prognostic value of a novel circulating serum 90K antigen in breast cancer. Brit. J. Cancer, 69, 172-176 (1994).
11. IACOBELLI, S., ULLRICH, A., TINARI, N., ORTONA, L., TAMBURRINI, E., D'EGIDIO, M., GHINELLI, F., SIGHINOLFI, L., PIAZZA, M., CHIRIANNI, A., GUERRA, L. and NATOLI, C., The 90K tumor-associated antigen and clinical progression in human-immunodeficiency-virus infection. J. AIDS, 10, 450-456 (1995).
12. INOHARA, H., AKAHANI, S., KOTHS, K. and RAZ, A., Interactions between galectin-3 and Mac-2 binding protein mediate cell-cell adhesion. Cancer Res., 56, 4530-4534 (1996).
13. JALLAL, B., POWELL, J., BRAKEBVSCH, C., GERMAIN, L., JACOBS, J., IACOBELLI, S. and ULLRICH, A., Suppression of tumor growth in vivo by local and systemic 90K level increase. Cancer Res., 55, 3223-3227 (1995).
14. KAPLAN, E.L. and MEIER, P., Non-parametric estimation from incomplete observation. J. Amer. statist. Ass., 53, 457-481 (1958).
15. LOTZ, M.M., ANDREWS, C.W., KORZELIUS, C.A., LEE, E.C., STEELE, G.D., CLARKE, A. and MERCURIC, A.M., Decreased expression of Mac-2 (carbohydrate-binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc. nat. Acad. Sci. (Wash.), 90, 3466-3470 (1993).
16. NATOLI, C., GARUFI, C., TINARI, N., D'EGIDIO, M., LESTI, G., GASPARI, L.A., VISINI, R. and IACOBELLI, S., Dynamic test with recombinant interteron-α2b: effect on 90K and other tumor-associated antigens in cancer patients without evidence of disease. Brit. J. Cancer 67, 564-567 (1993).
17. NATOLI, C., IACOBELLI, S. and KOHN, L.D., The immune stimulatory protein 90K increases major-histocompatibility-complex-class-I expression in a human breast-cancer cell line. Biochem. biophys. Res. Comm., 225, 617-620 (1996).
18. POWELL, J., SCHRECK, R., MCCALL, M., HUI, T., RICE, A., APP, H., AZAM, M., ULLRICH, A, and SHAWVER, L., A tumor-derived protein which provides T-cell co-stimulation through accessory cell activation. J. Immunother., 17, 209-211 (1995).
19. QUERZOLI, P., FERRETTI, S., ALBONICO, G., MAORI, E., SCAPOLI, D. INDELLI, M. and NENCI, I., Application of quantitative analysis to biologic profile evaluation in breast cancer. Cancer, 76, 2510-2517 (1995).
20. SENALDI, G., PEAKMAN, M., NATOLI, C., HUSSAIN, M.J., GALLATI, H., MCMANUS, T., VERGANI, D. and IACOBELLI, S., Relationship between the tumour-associated antigen 90K and cytokines in the circulation of persons infected with human immunodeficiency virus. J. Infection, 28, 31-39 (1994).
21. SILVESTRINI, R., BENINI, E., DAIDONE, M.G., VENERONI, S., BORACCHI, P. and CAPPELLETTI, V., p53 as an independent prognostic marker in lymph-node-negative breast-cancer patients. J. nat. Cancer Inst., 85, 965-970 (1993).
22. SLAMON, D.J., GODOLPHIN, W., JONES, L.A., HOLT, J.A., WOING, S.G., KEITH, D.E., LEVIN, W.J., STUART, S.G., UDOVE, J., ULLRICH, A. and PRESS, M.F., Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712 (1989).
23. TINARI, N., D'EGIDIO, M., IACOBELLI, S., BOWEN, M., STARLING, G., SEACHORD, C., DARVEAU, R. and ARUFFO, A., Identification of the tumor antigen 90K domains recognized by monoclonal antibodies SP2 and L3 and preparation and characterization of novel anti-90K monoclonal antibodies. Biochem. biophys. Res. Comm., 232, 367-372 (1997).
24. ULLRICH, A. and 12 OTHERS, The secreted tumor-associated antigen 90K is a potent immune stimulator. J. biol. Chem., 269, 18401-18407 (1994).